AMBROZOVÁ, Laura, Tomáš ZEMAN, Vladimír JANOUT, Jana JANOUTOVÁ, Jan LOCHMAN and Omar ŠERÝ. Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report. Journal of Clinical Laboratory Analysis. Wiley, 2023, vol. 37, 13-14, p. 1-7. ISSN 0887-8013. Available from: https://dx.doi.org/10.1002/jcla.24949.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report
Authors AMBROZOVÁ, Laura (703 Slovakia, belonging to the institution), Tomáš ZEMAN (203 Czech Republic, belonging to the institution), Vladimír JANOUT, Jana JANOUTOVÁ, Jan LOCHMAN (203 Czech Republic, belonging to the institution) and Omar ŠERÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Journal of Clinical Laboratory Analysis, Wiley, 2023, 0887-8013.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.700 in 2022
RIV identification code RIV/00216224:14310/23:00134349
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1002/jcla.24949
UT WoS 001036281600001
Keywords in English candidate gene analyses; genetic association study; insulin-degrading enzyme (IDE); miRNA; schizophrenic disorder; single nucleotide polymorphism (SNP)
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 3/1/2024 11:28.
Abstract
Background Insulin-degrading enzyme (IDE) is an important gene in studies of the pathophysiology of type 2 diabetes mellitus (T2DM). Recent studies have suggested a possible link between type 2 diabetes mellitus (T2DM) and the pathophysiology of schizophrenia (SZ). At the same time, significant changes in insulin-degrading enzyme (IDE) gene expression have been found in the brains of people with schizophrenia. These findings highlight the need to further investigate the role of IDE in schizophrenia pathogenesis. Methods We enrolled 733 participants from the Czech Republic, including 383 patients with schizophrenia and 350 healthy controls. Our study focused on the single nucleotide polymorphism (SNP) rs2421943 in the IDE gene, which has previously been associated with the pathogenesis of Alzheimer's disease. The SNP was analyzed using the PCR-RFLP method. Results The G allele of the rs2421943 polymorphism was found to significantly increase the risk of developing SZ (p < 0.01) when a gender-based analysis showed that both AG and GG genotypes were associated with a more than 1.55 times increased risk of SZ in females (p < 0.03) but not in males. Besides, we identified a potential binding site at the G allele locus for has-miR-7110-5p, providing a potential mechanism for the observed association. Conclusion Our results confirm the role of the IDE gene in schizophrenia pathogenesis and suggest that future research should investigate the relationship between miRNA and estrogen influence on IDE expression in schizophrenia pathogenesis.
Links
GP309/09/P361, research and development projectName: Vztah interakce polymorfismů kandidátních genů k patogenezi schizofrenie
Investor: Czech Science Foundation, Relationship of candidate genes polymorphisms interaction to pathogenesis of schizophrenia
PrintDisplayed: 2/7/2024 10:42